Skip to main content
Budesonide
prod 6

Budesonide

Status

Commercial

Therapeutic Category

Anti-inflammatory

Pharmacopoeia

IP/ BP /EP

Cas no.

5133 – 22 – 3

DMF Status

CEP No. R1-CEP 2014 – 177-Rev 00

Product Remarks

ANVISA, KFDA, CDE-NMPA, PATENT GRANTED

International Patent

WO 2018/033939 A1

Indian Patent

IN295893

Application - suspension, capsule, tablet, inhaler, injectables

Drug Description

Budesonide extended-release capsules are indicated for the treatment and maintenance of mild to moderate Crohn’s disease. Various inhaled budesonide products are indicated for prophylactic therapy in asthma and to reduce exacerbations of COPD. A budesonide nasal spray is available over the counter for symptoms of hay fever and upper respiratory allergies.

Contact Us

Connect with Avik Today

    Cynthia Lobo

    Manager – International Marketing

    Cynthia Lobo, a graduate of Mumbai University, brings with her 18 years of professional experience, including 16 years in the pharmaceutical industry. She independently manages key international markets such as Europe, CIS, and Egypt, along with several Asian countries including China, Malaysia, Sri Lanka, Taiwan, Thailand, Singapore, and Hong Kong.

    Cynthia is known for building and maintaining strong, long-term relationships with customers and agents across these regions.

    Mobile No: 9821827247
    Email Id: cynthia@avikpharma.com

    Jayprakash Rajbhar

    Manager – International Marketing

    A marketing professional with over 20 years in the Pharmaceutical API manufacturing sector, showcasing expertise in business development. Offers comprehensive insight into the pharma landscape with strength in Customer service management, Business processes, Analytics, Forecasting and Cross functional leadership.

    I have always believed that success isn’t just about numbers, it’s about impact, it’s about the lives we touch, the opportunities we create, and the differences we make along the way.

    To me, leadership is about inspiring, empowering, and making a difference, because real success isn’t just about what we achieve, but about the legacy of impact, opportunity, and meaningful change we leave behind.

    Mobile No: +91 -7757985269 / 8779721345
    Email Id: jaiprakash@avikpharma.com

    Uttam Shetty

    Manager – Domestic Marketing

    With over 35 years of experience in the pharmaceutical API manufacturing sector, I began my career in Import Documentation before moving into API & Chemical Procurement—a challenging yet highly rewarding phase. I then transitioned into Marketing, where I embraced significant challenges that not only strengthened my professional capabilities but also gave me the opportunity to work closely with both management and customers.

    This journey has been deeply fulfilling, marked by continuous growth, adaptability, and a passion for delivering value. My skills have been shaped through years of dedicated practice and hands-on experience, while my achievements stand as tangible milestones of excellence within my field.

    Mobile No: 9320121167
    Email Id: uttams@avikpharma.com

    Dr. Abhay Kumar Chheda

    President Operations

    A Ph.D. in Organic Chemistry, Dr. Chheda has 25+ years of experience in R&D, manufacturing, and regulatory functions across steroidal and high-potency APIs. His expertise has played a key role in Avik’s technical and operational growth.

    Neha Thakore

    Chief Operating Officer

    Neha Thakore, Chief Operating Officer at Avik Pharmaceutical, brings over 25 years of industry expertise to her role. Under her leadership, Avik has strengthened its position as a compliant manufacturer of corticosteroids. Inspired by a family legacy rooted in pharma innovation, Neha combines strategic foresight with a commitment to quality and global standards. Also serving as Vice Chairperson of the IDMA API Committee, she continues to drive Avik toward sustained growth and industry excellence.

    Anant Thakore

    Founder

    Mr. Anant Thakore, a law graduate, entered the pharma industry during the License Raj era and played a pivotal role in shaping pro-industry policies. As IDMA President, he promoted globalization by encouraging Indian API manufacturers to engage in international trade. He grew his business into a diversified group and has mentored many across the sector. In recognition of his contributions, IDMA honoured him as "Chief Mentor of the Year" in 2016.